{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:17:27Z","timestamp":1787732247512,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41417-026-01062-3","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T14:48:31Z","timestamp":1784990911000},"page":"1029-1040","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HOXC11 promotes head and neck squamous cell carcinomas (HNSCC) progression by regulating SPHK1 through the Wnt signaling pathway"],"prefix":"10.1038","volume":"33","author":[{"given":"Jing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qionghui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9631-7261","authenticated-orcid":false,"given":"Jingyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"1062_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6:92.","journal-title":"Nat Rev Dis Primers"},{"key":"1062_CR2","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.6004\/jnccn.2014.0142","volume":"12","author":"DG Pfister","year":"2014","unstructured":"Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, et al. Head and neck cancers, version 2.2014. J Natl Compr Cancer Netw. 2014;12:1454\u201387.","journal-title":"J Natl Compr Cancer Netw"},{"key":"1062_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105356","volume":"119","author":"D Berzenji","year":"2021","unstructured":"Berzenji D, Sewnaik A, Keereweer S, Monserez DA, Verduijn GM, van Meerten E, et al. Dissemination patterns and chronology of distant metastasis affect survival of patients with head and neck squamous cell carcinoma. Oral Oncol. 2021;119:105356.","journal-title":"Oral Oncol"},{"key":"1062_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.14639\/0392-100X-suppl.1-40-2020","volume":"40","author":"P Pisani","year":"2020","unstructured":"Pisani P, Airoldi M, Allais A, Valletti PA, Battista M, Benazzo M, et al. Metastatic disease in head & neck oncology. Acta Otorhinolaryngol Ital. 2020;40:S1.","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"1062_CR5","first-page":"859","volume":"5","author":"SM Hrycaj","year":"2016","unstructured":"Hrycaj SM, Wellik DM. Hox genes and evolution. Research. 2016;5:859.","journal-title":"Research"},{"key":"1062_CR6","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3892\/ol.2016.4901","volume":"12","author":"Y Wang","year":"2016","unstructured":"Wang Y, Dang Y, Liu J, Ouyang X. The function of homeobox genes and lncRNAs in cancer. Oncol Lett. 2016;12:1635\u201341.","journal-title":"Oncol Lett"},{"key":"1062_CR7","doi-asserted-by":"publisher","first-page":"3569493","DOI":"10.1155\/2018\/3569493","volume":"2018","author":"S Bhatlekar","year":"2018","unstructured":"Bhatlekar S, Fields JZ, Boman BM. Role of HOX genes in stem cell differentiation and cancer. Stem Cells Int. 2018;2018:3569493.","journal-title":"Stem Cells Int"},{"key":"1062_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3390\/cancers11040528","volume":"11","author":"B Li","year":"2019","unstructured":"Li B, Huang Q, Wei G-H. The role of HOX transcription factors in cancer predisposition and progression. Cancers. 2019;11:528.","journal-title":"Cancers"},{"key":"1062_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/1010428320918050","volume":"42","author":"Brotto","year":"2020","unstructured":"Brotto, Siena DB, de Barros II \u00c1DD, Carvalho, SdCeS, Muys BR, et al. Contributions of HOX genes to cancer hallmarks: Enrichment pathway analysis and review. Tumor Biol. 2020;42:1010428320918050.","journal-title":"Tumor Biol"},{"key":"1062_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02601-1","volume":"9","author":"T Yan","year":"2018","unstructured":"Yan T, Ooi WF, Qamra A, Cheung A, Ma D, Sundaram GM, et al. HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis. Nat Commun. 2018;9:100.","journal-title":"Nat Commun"},{"key":"1062_CR11","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.prp.2018.09.001","volume":"214","author":"T-f Yan","year":"2018","unstructured":"Yan T-f, Wu M-j, Xiao B, Hu Q, Fan Y-H, Zhu X-G. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and in vivo. Pathol-Res Pract. 2018;214:1818\u201324.","journal-title":"Pathol-Res Pract"},{"key":"1062_CR12","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1096\/fj.201801099RR","volume":"33","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wang C, Liu N, Hou J, Xiao W, Wang H. HOXC6 promotes cervical cancer progression via regulation of Bcl-2. FASEB J. 2019;33:3901\u201311.","journal-title":"FASEB J"},{"key":"1062_CR13","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.6629","volume":"7","author":"Y Yang","year":"2019","unstructured":"Yang Y, Tang X, Song X, Tang L, Cao Y, Liu X, et al. Evidence for an oncogenic role of HOXC6 in human non-small cell lung cancer. PeerJ. 2019;7:e6629.","journal-title":"PeerJ"},{"key":"1062_CR14","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1002\/mc.23079","volume":"58","author":"C Gong","year":"2019","unstructured":"Gong C, Zou J, Zhang M, Zhang J, Xu S, Zhu S, et al. Upregulation of MGP by HOXC8 promotes the proliferation, migration, and EMT processes of triple-negative breast cancer. Mol Carcinogenesis. 2019;58:1863\u201375.","journal-title":"Mol Carcinogenesis"},{"key":"1062_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7754\/Clin.Lab.2019.190122","volume":"65","author":"M Hu","year":"2019","unstructured":"Hu M, Ou-Yang W, Jing D, Chen R. Clinical prognostic significance of HOXC9 expression in patients with colorectal cancer. Clin Lab. 2019;65:10.","journal-title":"Clin Lab"},{"key":"1062_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/1061186X.2018.1473408","volume":"27","author":"Y Guan","year":"2019","unstructured":"Guan Y, He Y, Lv S, Hou X, Li L, Song J. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K\/AKT signalling pathway. J Drug Target. 2019;27:60\u20136.","journal-title":"J Drug Target"},{"key":"1062_CR17","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.7150\/jca.30645","volume":"10","author":"BW Dai","year":"2019","unstructured":"Dai BW, Yang ZM, Deng P, Chen YR, He ZJ, Yang X, et al. HOXC10 promotes migration and invasion via the WNT-EMT signaling pathway in oral squamous cell carcinoma. J Cancer. 2019;10:4540\u201351.","journal-title":"J Cancer"},{"key":"1062_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3892\/ijo.2023.5598","volume":"64","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Huang Q, Wu C, Xu Y, Guo Y, Yuan X. et al. m(6)A\u2011modified HOXC10 promotes HNSCC progression via co\u2011activation of ADAM17\/EGFR and Wnt\/beta\u2011catenin signaling. Int J Oncol. 2024;64:10","journal-title":"Int J Oncol"},{"key":"1062_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.117230","volume":"243","author":"Y Cui","year":"2020","unstructured":"Cui Y, Zhang C, Wang Y, Ma S, Cao W, Guan F. HOXC11 functions as a novel oncogene in human colon adenocarcinoma and kidney renal clear cell carcinoma. Life Sci. 2020;243:117230.","journal-title":"Life Sci"},{"key":"1062_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/1073274820976664","volume":"27","author":"X Wang","year":"2020","unstructured":"Wang X, Sun Y, Peng X, Naqvi SMAS, Yang Y, Zhang J, et al. The tumorigenic effect of sphingosine kinase 1 and its potential therapeutic target. Cancer Control. 2020;27:1073274820976664.","journal-title":"Cancer Control"},{"key":"1062_CR21","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1111\/odi.13492","volume":"26","author":"L Zhu","year":"2020","unstructured":"Zhu L, Yan D, Chen Y, Chen S, Chen N, Han J. The identification of autophagy-related genes in the prognosis of oral squamous cell carcinoma. Oral Dis. 2020;26:1659\u201367.","journal-title":"Oral Dis"},{"key":"1062_CR22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.37080\/nmj.147","volume":"4","author":"BB Karki","year":"2021","unstructured":"Karki BB, Wu D, Shen J. Sphingosine kinase 1 (SphK1)\u2013a novel marker for cancer risk assessment in oral premalignancy. Nepal Med J. 2021;4:58\u201367.","journal-title":"Nepal Med J"},{"key":"1062_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41419-023-05673-8","volume":"14","author":"X Peng","year":"2023","unstructured":"Peng X, Liu X, Hu W, Zhou Y, Ouyang L, Peng X, et al. HOXC11 drives lung adenocarcinoma progression through transcriptional regulation of SPHK1. Cell Death Dis. 2023;14:153.","journal-title":"Cell Death Dis"},{"key":"1062_CR24","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1177\/0022034518771923","volume":"97","author":"KA Abalkhail","year":"2018","unstructured":"Abalkhail KA, Kukuruzinska MA. Emerging insights into Wnt\/beta-catenin signaling in head and neck cancer. J Dent Res. 2018;97:665\u201373.","journal-title":"J Dent Res"},{"key":"1062_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155481","volume":"260","author":"Q Wang","year":"2024","unstructured":"Wang Q, Meng D, Shen S, Cao Y, Zhang P, Liu Y, et al. P4HA3 promotes head and neck squamous cell carcinoma progression via the WNT\/beta-catenin signaling pathway. Pathol Res Pract. 2024;260:155481.","journal-title":"Pathol Res Pract"},{"key":"1062_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.lfs.2016.02.098","volume":"151","author":"H Liu","year":"2016","unstructured":"Liu H, Zhang CX, Ma Y, He HW, Wang JP, Shao RG. SphK1 inhibitor SKI II inhibits the proliferation of human hepatoma HepG2 cells via the Wnt5A\/beta-catenin signaling pathway. Life Sci. 2016;151:23\u20139.","journal-title":"Life Sci"},{"key":"1062_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jdsr.2023.10.003","volume":"60","author":"S Khijmatgar","year":"2024","unstructured":"Khijmatgar S, Yong J, R\u00fcbsamen N, Lorusso F, Rai P, Cenzato N, et al. Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head\/neck squamous cell carcinoma (HNSCC): A systematic review and network meta-analysis. Jpn Dent Sci Rev. 2024;60:32\u20139.","journal-title":"Jpn Dent Sci Rev"},{"key":"1062_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/medsci11020042","volume":"11","author":"A Barsouk","year":"2023","unstructured":"Barsouk A, Aluru JS, Rawla P, Saginala K, Barsouk A. Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma. Med Sci. 2023;11:42.","journal-title":"Med Sci"},{"key":"1062_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-023-03277-2","volume":"22","author":"J Li","year":"2024","unstructured":"Li J, Feng L, Yuan Y, He T, Zou X, Su B, et al. Inhibition of HOXC11 by artesunate induces ferroptosis and suppresses ovarian cancer progression through transcriptional regulation of the PROM2\/PI3K\/AKT pathway. World J Surg Oncol. 2024;22:1\u201316.","journal-title":"World J Surg Oncol"},{"key":"1062_CR30","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1089\/dna.2021.0368","volume":"40","author":"L Liu","year":"2021","unstructured":"Liu L, Jia S, Jin X, Zhu S, Zhang S. HOXC11 expression is associated with the progression of colon adenocarcinoma and is a prognostic biomarker. DNA Cell Biol. 2021;40:1158\u201366.","journal-title":"DNA Cell Biol"},{"key":"1062_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12698-5","volume":"24","author":"S Chu","year":"2024","unstructured":"Chu S, Ren X, Cao L, Ma C, Wang K. HOXC11-mediated regulation of mitochondrial function modulates chemoresistance in colorectal cancer. BMC Cancer. 2024;24:921.","journal-title":"BMC Cancer"},{"key":"1062_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14412-6","volume":"12","author":"KSR Padam","year":"2022","unstructured":"Padam KSR, Morgan R, Hunter K, Chakrabarty S, Kumar NA, Radhakrishnan R. Identification of HOX signatures contributing to oral cancer phenotype. Sci Rep. 2022;12:10123.","journal-title":"Sci Rep"},{"key":"1062_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s43556-024-00196-w","volume":"5","author":"J Yang","year":"2024","unstructured":"Yang J, Li J, Li S, Yang Y, Su H, Guo H, et al. Effects of HOX family regulator-mediated modification patterns and immunity characteristics on tumor-associated cell type in endometrial cancer. Mol Biomed. 2024;5:32.","journal-title":"Mol Biomed"},{"key":"1062_CR34","doi-asserted-by":"publisher","first-page":"7386","DOI":"10.1245\/s10434-022-12098-8","volume":"29","author":"C-x Hou","year":"2022","unstructured":"Hou C-x, Mao G-y, Sun Q-w, Meng Y, Zhu Q-h, Tang Y-t, et al. Metabolomic analysis reveals that SPHK1 promotes oral squamous cell carcinoma progression through NF-\u03baB activation. Ann Surg Oncol. 2022;29:7386\u201399.","journal-title":"Ann Surg Oncol"},{"key":"1062_CR35","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/biom3030481","volume":"3","author":"PM Tamashiro","year":"2013","unstructured":"Tamashiro PM, Furuya H, Shimizu Y, Iino K, Kawamori T. The impact of sphingosine kinase-1 in head and neck cancer. Biomolecules. 2013;3:481\u2013513.","journal-title":"Biomolecules"},{"key":"1062_CR36","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1158\/1940-6207.CAPR-10-0299","volume":"4","author":"K Shirai","year":"2011","unstructured":"Shirai K, Kaneshiro T, Wada M, Furuya H, Bielawski J, Hannun YA, et al. A role of sphingosine kinase 1 in head and neck carcinogenesis. Cancer Prev Res. 2011;4:454\u201362.","journal-title":"Cancer Prev Res"},{"key":"1062_CR37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.2174\/1871520621666210401105344","volume":"22","author":"J Long","year":"2022","unstructured":"Long J, Yao Z, Sui Y, Fang S. SphK1 promotes cancer progression through activating the JAK\/STAT pathway and up-regulating S1PR1 expression in colon cancer cells. Anti-Cancer Agents Med Chem. 2022;22:254\u201360.","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"1062_CR38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41419-023-06023-4","volume":"14","author":"L Jin","year":"2023","unstructured":"Jin L, Zhu J, Yao L, Shen G, Xue B-x, Tao W. Targeting SphK1\/2 by SKI-178 inhibits prostate cancer cell growth. Cell Death Dis. 2023;14:537.","journal-title":"Cell Death Dis"},{"key":"1062_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117123","volume":"177","author":"I Shakeel","year":"2024","unstructured":"Shakeel I, Haider S, Khan S, Ahmed S, Hussain A, Alajmi MF, et al. Thymoquinone, artemisinin, and thymol attenuate the proliferation of lung cancer cells as Sphingosine kinase 1 inhibitors. Biomed Pharmacother. 2024;177:117123.","journal-title":"Biomed Pharmacother"},{"key":"1062_CR40","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41419-024-07044-3","volume":"15","author":"W-H Kao","year":"2024","unstructured":"Kao W-H, Liao L-Z, Chen Y-A, Lo U-G, Pong R-C, Hernandez E, et al. SPHK1 promotes bladder cancer metastasis via PD-L2\/c-Src\/FAK signaling cascade. Cell Death Dis. 2024;15:678.","journal-title":"Cell Death Dis"},{"key":"1062_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03221-8","volume":"24","author":"SS Alkafaas","year":"2024","unstructured":"Alkafaas SS, Elsalahaty MI, Ismail DF, Radwan MA, Elkafas SS, Loutfy SA, et al. The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target. Cancer Cell Int. 2024;24:89.","journal-title":"Cancer Cell Int"},{"key":"1062_CR42","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/cancers11040512","volume":"11","author":"J Smith","year":"2019","unstructured":"Smith J, Zyoud A, Allegrucci C. A case of identity: HOX genes in normal and cancer stem cells. Cancers. 2019;11:512.","journal-title":"Cancers"},{"key":"1062_CR43","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ydbio.2016.12.024","volume":"422","author":"R Neijts","year":"2017","unstructured":"Neijts R, Amin S, van Rooijen C, Deschamps J. Cdx is crucial for the timing mechanism driving colinear Hox activation and defines a trunk segment in the Hox cluster topology. Dev Biol. 2017;422:146\u201354.","journal-title":"Dev Biol"},{"key":"1062_CR44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.canlet.2017.09.019","volume":"410","author":"Z Fu","year":"2017","unstructured":"Fu Z, Chen C, Zhou Q, Wang Y, Zhao Y, Zhao X, et al. LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. Cancer Lett. 2017;410:68\u201381.","journal-title":"Cancer Lett"},{"key":"1062_CR45","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ccell.2015.11.001","volume":"28","author":"P Ord\u00f3\u00f1ez-Mor\u00e1n","year":"2015","unstructured":"Ord\u00f3\u00f1ez-Mor\u00e1n P, Dafflon C, Imajo M, Nishida E, Huelsken J. HOXA5 counteracts stem cell traits by inhibiting Wnt signaling in colorectal cancer. Cancer cell. 2015;28:815\u201329.","journal-title":"Cancer cell"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01062-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01062-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01062-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:17:45Z","timestamp":1787728665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01062-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1062"],"URL":"https:\/\/doi.org\/10.1038\/s41417-026-01062-3","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}